StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX cash

Cash and short-term investments held at the end of each period.

NewcelX's cash was $710.00K at Jun 30, 2026. For fiscal 2025 it was $2.20M, up 238.6% from the year before. The highest annual figure on record is $5.43M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.20M+238.6%
FY2024Dec 31, 2024$650.00K-43.3%
FY2023Dec 31, 2023$1.15M-41.9%
FY2022Dec 31, 2022$1.97M-63.7%
FY2021Dec 31, 2021$5.43M+5695.7%
FY2020Dec 31, 2020$93.71K-57.5%
FY2019Dec 31, 2019$220.27K+3198.4%
FY2018Dec 31, 2018$6.68K-99.7%
FY2017Dec 31, 2017$2.18M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$710.00K+28.4%
Q4 FY2025Dec 31, 2025$2.20M+92.1%
Q2 FY2025Jun 30, 2025$299.00K-81.9%
Q4 FY2024Dec 31, 2024$650.00K-67.1%
Q2 FY2024Jun 30, 2024$552.76K-59.2%
Q4 FY2023Dec 31, 2023$1.15M-78.9%
Q2 FY2023Jun 30, 2023$1.65M-76.7%
Q4 FY2022Dec 31, 2022$1.97M+2006.5%
Q2 FY2022Jun 30, 2022$1.35M+831.3%
Q4 FY2021Dec 31, 2021$5.43M+2365.7%
Q2 FY2021Jun 30, 2021$7.09M+106101.2%
Q4 FY2020Dec 31, 2020$93.71K-95.7%
Q2 FY2020Jun 30, 2020$145.40K–
Q4 FY2019Dec 31, 2019$220.27K–
Q4 FY2018Dec 31, 2018$6.68K–
Q4 FY2017Dec 31, 2017$2.18M–

More NewcelX figures

See a number that looks wrong?